India’s booming obesity drug market is finding a new and highly visible niche, the pre-wedding makeover. Clinics in major cities are increasingly folding GLP-1 receptor agonists and related anti-obesity medications into “bridal” and “groom” transformation packages, alongside the more familiar offerings of skincare, hair, and fitness support. What was once largely a metabolic medicine conversation is now showing up in wedding planning. Doctors across India report a noticeable rise in inquiries from soon-to-be brides and, to a lesser extent, grooms seeking rapid weight reduction ahead of wedding dates.
Many patients are arriving not only with a target weight in mind, but also with a countdown. Among the most requested agents is tirzepatide, marketed globally as Mounjaro for diabetes management and Zepbound for weight management. In India, however, the drug has quickly gained traction and…
